Finch Therapeutics Group, Inc. Stock Forecast
Finch Therapeutics Group, Inc. stock price took a fall of -5.08% on Friday
(Updated on Apr 19, 2024)
The Finch Therapeutics Group, Inc. stock price fell by -5.08% on the last day (Friday, 19th Apr 2024) from $2.36 to $2.24. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 6.02% from a day low at $2.16 to a day high of $2.29. The price has fallen in 7 of the last 10 days but is still up by 1.77% over the past 2 weeks. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 30 thousand shares were bought and sold for approximately $66.85 thousand.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.00 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.41% during the next 3 months and, with a 90% probability hold a price between $1.79 and $2.91 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
FNCH Signals & Forecast
There are few to no technical positive signals at the moment. The Finch Therapeutics Group, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.41 and $2.55. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -27.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Finch Therapeutics Group, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Finch Therapeutics Group, Inc. stock
Finch Therapeutics Group, Inc. finds support from accumulated volume at $2.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.130 between high and low, or 6.02%. For the last week, the stock has had daily average volatility of 26.68%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (FNCH) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Finch Therapeutics Group, Inc. to open at $2.23, and during the day (based on 14 day Average True Range), to move between $1.86 and $2.62, which gives a possible trading interval of +/-$0.377 (+/-16.84%) up or down from last closing price. If Finch Therapeutics Group, Inc. takes out the full calculated possible swing range there will be an estimated 33.68% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.20 (1.74%) than the resistance at $2.50 (11.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Finch Therapeutics Group, Inc. stock A Buy?
Finch Therapeutics Group, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -4.698 Sell Candidate Upgraded
Predicted Opening Price for Finch Therapeutics Group, Inc. of Monday, April 22, 2024
| Fair opening price April 22, 2024 | Current price |
|---|---|
| $2.23 ( 0.446%) | $2.24 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for FNCH
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.36 | 5.36 % | |
| R2 | 2.31 | 3.14 % | ||
| R1 | 2.28 | 1.77 % | ||
| Current price: | 2.24 | |||
| Support | S1 | 2.18 | -2.66 % | |
| S2 | 2.15 | -4.03 % | ||
| S3 | 2.10 | -6.25 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.69 | 20.09 % | |
| R2 | 2.52 | 12.50 % | ||
| R1 | 2.50 | 11.61 % | ||
| Current price | 2.24 | |||
| Support | S1 | 2.20 | -1.74% | |
| S2 | 2.20 | -1.79% | ||
| S3 | 2.03 | -9.38% |
FAQ
Click here for our free guide on how to buy Finch Therapeutics Group, Inc. Stock.
